Ultrasound-Guided Hydrodilatation With Triamcinolone Acetonide for Adhesive Capsulitis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorGeneral Hospital of Ningxia Medical University

About this trial

The purpose of this study was to compare the efficacy of ultrasus-guided hydrodilation of Rotator Cuff Interval combined with Posterior Glenohumeral recess approach and hydrodilation of the Rotator cuff Interval alone in Adhesive Capsulitis.

Eligibility criteria

Qualifiers

Age ≥18 years old, clinical diagnosis of periarthritis of shoulder;

symptom duration > 1 month, shoulder ROM limitation in at least two directions, defined as abduction < 80°, flexion < 130°, and rotation < 30°;

Before enrollment, the patients received plain radiographs, ultrasound images, and magnetic resonance imaging to rule out the cause of secondary shoulder capsitis.

Disqualifiers

Secondary frozen shoulder, such as rotator cuff tear, calcifying tendinitis, osteoarthritis, infection, tuberculosis infection, rheumatic disease, shoulder impingement syndrome;

Previous history of shoulder joint surgery;

Involved cervical nervous system symptoms or abnormal nervous system;

corticosteroid injection in the affected shoulder within 3 months;

Trial design

Treatments tested in this trial

  • Ultrasound-Guided Hydrodilatation by the Rotator cuff interval recess
  • Ultrasound-Guided Hydrodilatation by the Rotator cuff interval and posterior glenohumeral recess

Treatment groups

70 Participants
are divided into 2 treatment groups